Plusman LLC is a Tokyo-based R&D company focused on mathematical engineering and deep learning. Its official positioning emphasizes “Integrity,” “Non-centralized Expertise,” and “Contribution.” Based on the publicly available content, it is not a general-purpose AI tool for individual users, but rather a technology company engaged in R&D—and, in some areas, manufacturing and sales—across medical imaging, pharmaceutical R&D, general artificial intelligence, quantum cryptography, and system trading.
Its AI capabilities are mainly centered on Deep Learning. In medical imaging, Plusman uses image-based deep learning for diagnostic imaging support, while developing Computer Aided Detection / Diagnosis technologies, image segmentation programs, and MR/CT image conversion and processing technologies. In pharmaceuticals, its work includes compound and peptide exploration using 3D Deep Learning + MCMC, as well as pathology analysis with Graph Convolution. The official website also mentions language, reinforcement learning, graph-structure, and image-based technologies for research into language-acquisition AI, including more frontier-oriented explorations such as translation of undeciphered languages and animal communication.
The official website does not disclose any standard pricing, free trial, procurement process, or payment methods. It also does not state whether API, SDK, cloud services, or integration with hospital/pharmaceutical company systems are available. As a result, it is difficult to evaluate its usability and cost-effectiveness in the same way as a conventional AI SaaS product. Engagement is more likely to take the form of project collaboration, joint R&D, or medical device procurement.
Its strengths lie in broad technical coverage, along with a Type II medical device manufacturing and sales license and medical device manufacturing registration. The website lists Bayer Yakuhin, Juntendo University, Mie University, Tokyo Medical and Dental University, Hokkaido University, and The Cancer Institute Hospital of JFCR among its deployment or collaboration partners, indicating a certain level of connectivity within the medical research ecosystem. The limitations are that the publicly available information is mostly company-oriented, with few details on specific product names, clinical validation metrics, model accuracy, data privacy policies, or commercial terms, making it hard for external users to directly assess product maturity.
Plusman is better suited to hospital imaging departments, medical AI research teams, pharmaceutical companies, university laboratories, and organizations looking for medical AI partners in Japan. It is not a good fit for individuals or small and midsize teams seeking ready-to-use AI applications. Information on access from mainland China, Chinese-language support, and cross-border payments is not provided in the public content, so the status should be considered unknown. For use in domestic Chinese medical scenarios, local approved medical imaging AI vendors and compliant alternatives should also be compared.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on plusmanllc.co.jp official site.
plusmanllc.co.jp is an Japan AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach plusmanllc.co.jp directly.